Optimal Duration of Dual Antiplatelet Therapy After Stent-assisted Coiling
Key facts
- Who runs it
- Seoul National University Bundang Hospital
- Where
- South Korea8 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- Phase
- Phase 4
- People taking part
- 528 people enrolled
- Started
- 23 Jun 2022
- Ended
- 2 Dec 2025
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Aspirin 100mg
- Clopidogrel 75mg
- Record updated
- 19 December 2025
Who can take part
- Age
- 19 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 22 criteriaShow less
Who can take part
- subjects over 19 years old
- subjects with modified Rankin Scale (mRS) ≤ 2
- subjects with unruptured intracranial aneurysms
- subjects with appropriated aspirin and clopidogrel reaction units after dual antiplatelet preparation (100 mg of aspirin and 75 mg of clopidogrel) for at least 5 days before procedure [measured using VerifyNow]; aspirin reaction unit (ARU) < 550; P2Y12 reaction unit (PRU): 85~219
- subjects who agreed to this study (with informed consent)
Who cannot take part
- subjects with an allergic reaction to antiplatelets (aspirin and clopidogrel) or contrast
- subjects with a high risk of hemorrhage such ICH or severe gastric ulceration
- subjects with liver diseases (> 100IU/L of aspartate aminotransferase or alanine aminotransferase)
- subjects with underlying diseases that need to maintain dual antiplatelet drugs or anticoagulants
- subjects with a high risk of strokes (atrial fibrillation, over 70% cerebral artery stenosis or cerebral artery occlusion, moyamoya disease, vascular malformations, etc)
- subjects with uncontrolled congestive heart failure or angina
- subjects with malignant tumors
- subjects with life-threatening diseases
- subjects with medical conditions with a life expectancy of less than two years
- subjects with renal diseases (> 2mg/dL of serum creatinine)
- subjects with a positive pregnancy test (serum or urine)
- subjects with neurological deficits (mRS ≥ 3)
- subjects with coagulopathy
- subjects with thrombocytopenia (<100,000/mm3)
- subjects who are unconscious at the time of diagnosis
- subjects who are unable to complete the required follow-ups
- subjects who are determined to be disqualified by researchers
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Comparison of duration of dual antiplatelet therapy after stent-assisted coiling of unruptured intracranial aneurysms
The 2 groups in the trial
- short-term dual antiplatelet groupExisting treatment, for comparison
Patients with unruptured intracranial aneurysms received dual antiplatelet agents (100mg of aspirin and 75mg of clopidogrel) for at least five days before coil embolization. One day prior to coiling, aspirin reaction units (ARU) and P2Y12 reaction units (PRU) were measured using VerifyNow. Patients with proper aspirin and clopidogrel reaction units (ARU \< 550 and PRU 85 \~219) will be enrolled in this study. After stent-assisted coiling, dual antiplatelet treatment continued for 6 months; after that time, this therapy will be exchanged for daily oral 100mg of aspirin for 18 months after coiling
Treatment: Aspirin 100mg and Clopidogrel 75mg
- long-term dual antiplatelet groupTreatment being tested
Patients with unruptured intracranial aneurysms received dual antiplatelet agents (100mg of aspirin and 75mg of clopidogrel) for at least five days before coil embolization. One day prior to coiling, aspirin reaction units (ARU) and P2Y12 reaction units (PRU) were measured using VerifyNow. Patients with proper aspirin and clopidogrel reaction units (ARU \< 550 and PRU 85 \~219) will be enrolled in this study. After stent-assisted coiling, dual antiplatelet treatment continued for 12 months; after that time, this therapy will be exchanged for daily oral 100mg of aspirin for 18 months after coiling.
Treatment: Aspirin 100mg and Clopidogrel 75mg
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Optimal Duration of Dual Antiplatelet Therapy After Stent-assisted Coiling of Unruptured Intracranial Aneurysms: A Prospective Randomized Multicenter Trial
- Record updated
- 19 December 2025